Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Low density lipoprotein, Lymphocyte count, Lymphocyte percentage, Mean arterial pressure, Mean cell haemoglobin
Clinical narrative: symptoms are progressively getting worse; shortness of breath; pain on the sides when he takes a deep breathe.; cough; Positive for orthopnea; This is a spontaneous report received from a Consumer or other non HCP.  A 78-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Nov2022 as dose 4, (booster) single (Lot number: GL0446) at the age of 78 years for covid-19 immunisation. The patient's relevant medical history included: "Abdominal pain" (ongoing); "Atrial fibrillation" (ongoing), notes: s/p Abbott Saint dual-chamber PPM in 2022 for SSS and ablation; "Cough" (ongoing); "Hypertension (HTN)" (ongoing); "Hyperlipidemia" (ongoing); "Seizures" (ongoing); "Ankle surgery" (unspecified if ongoing); "Ears surgery" (unspecified if ongoing); "Cataract surgery" (unspecified if ongoing); "Left Foot Surgery" (unspecified if ongoing); "1500 and 2000 indication: restless leg syndrome" (unspecified if ongoing); "pain" (unspecified if ongoing); "chronic diastolic heart failure" (unspecified if ongoing), notes: diastolic heart failure exacerbation; "underlying ckd" (unspecified if ongoing); "shortness of breath" (ongoing); "he has gained approximately 4 pounds in a week" (unspecified if ongoing); "back pain" (unspecified if ongoing); "CHF exacerbation" (unspecified if ongoing); "Paced rhythms" (unspecified if ongoing); "Tobacco use", start date: 1968 (unspecified if ongoing); "heart blockage" (ongoing); "Ineffective airway clearance" (ongoing); "sleep apnea" (ongoing); "Type B viral Hepatitis" (ongoing); "CHF" (ongoing); "Never smoker" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "sleep" (unspecified if ongoing); "Fever" (unspecified if ongoing); "cough/congestion" (unspecified if ongoing); "cough/congestion" (unspecified if ongoing); "Chest Pain" (unspecified if ongoing); "wheezing" (unspecified if ongoing); "coronary artery disease" (unspecified if ongoing); "VHD" (unspecified if ongoing), notes: moderate TR, mild-moderate MR on TEE in 2021. Concomitant medication(s) included: APIXABAN oral taken for atrial fibrillation; CLONIDINE oral; FUROSEMIDE oral taken for left ventricular failure; IBUPROFEN oral taken for back pain; LAMOTRIGINE oral; LEVOTHYROXINE oral; OLMESARTAN oral; LAMICTAL oral; XARELTO oral; AMLODIPINE BENAZEPRIL oral; TRAMADOL oral taken for pain; ZOLPIDEM oral taken for sleep disorder; ZYRTEC [CETIRIZINE HYDROCHLORIDE] oral taken for cough, nasal congestion; MELOXICAM oral taken for pain; PRAMIPEXOLE oral; TRAMADOL HCL; SOMADRIL [CARISOPRODOL]; VICODIN; TRAZODONE oral; BENZONATATE oral taken for cough; ETHANOL topical; POTASSIUM BICARBONATE oral; DEXTROMETHORPHAN/PROMETHAZINE oral; GUAIFENESIN oral; NALOXONE intravenous; ALBUTEROL [SALBUTAMOL] taken for wheezing; ATORVASTATIN oral; BUMETANIDE oral; CITALOPRAM oral; CLONAZEPAM oral; CYANOCOBALAMIN oral (ongoing); ERGOCALCIFEROL oral (ongoing); GABAPENTIN oral; HYDROCODONE/ACETAMINOPHEN oral taken for pain (ongoing); IPRATROPIUM/ALBUTEROL (ongoing); METOPROLOL oral; POTASSIUM CHLORIDE oral; PYRIDOXINE oral (ongoing); ROPINIROLE oral taken for restless legs syndrome; METOPROLOL SUCCINATE oral; MELATONIN oral; RIVAROXABAN oral; AMLODIPINE oral; AMLODIPINE/BENAZEPRIL oral; NITROGLYCERIN sublingual; HYDRALAZINE taken for blood pressure measurement. Vaccination history included: diphtheria/pertusis,acel/tetanus adult (Site: Left arm, Route: Intramuscular, Amount: 0.5 ml, Expiration date: 22Aug2020, Lot number: U6043BA), administration date: 15Nov2018, when the patient was 74-year-old, for Immunization; influenza virus vaccine, inactivated (Site: Left arm, Route: Intramuscular, Amount: 60 mcg, Expiration date: 30Jun2020, Lot number: TG729), administration date: 31Dec2019, when the patient was 75-year-old, for Immunization; BNT162b2 (1st dose; Pfizer BioNTech, 0.3 mL, Lot: EN6208, Expiry: 30Jun2021), administration date: 11Mar2021, when the patient was 76-year-old, for COVID-19 immunization, reaction(s): "I have been at the emergency room seven or eight times with heart problems/Damage that they did to my heart", "my blood pressure was like 200 over 100 and 10/Hypertensive crisis", "Could not breath", "Heartbeat went down to about 37 beat per minutes", "Damage they did to my psyche, to my brain", "High blood pressure", "Shortness of breath", "lower back pain", "I don't use to hear my voice", "Things are bad", "Damage they did to my psyche", "heart is not functioning properly"; BNT162b2 (2nd dose; Pfizer BioNTech, 0.3 mL, Lot: EP7533, Expiry: 31Jul2021), administration date: 01Apr2021, when the patient was 76-year-old, for COVID-19 immunization, reaction(s): "started having trouble with the heart/Damage that they did to my heart", "my blood pressure was like 200 over 100 and 10", "Could not breath", "Heartbeat went down to about 37 beat per minutes", "Damage they did to my psyche, to my brain", "I don't use to hear my voice", "Things are bad", "L3-S1 decompressive laminectomy with bilateral root decompression", "Atrial fibrillation CHADSVASC >2", "Pneumonia", "Myocardial infarction", "Arrhythmia", "Pulmonary embolism", "severe mitral regurgitation", "Chest pain", "Dyspnea on exertion", "AKI likely prerenal", "Paroxysmal atrial fibrillation", "HLD", "HTN", "Restless legs syndrome", "GERD", "congestive heart failure unknown type", "exacerbation of his atrial fibrillation", "lumbar spinal stenosis at L3-L4, L4-L5, and L5-S1", "had elevated creatlnine 1.8 with a GFR of 37/ Creatinine: 1.59 (H)/ Creatinine: 1.62 (H)/ 1.27 (H)", "LV (left ventricular) PW (posterior wall) thickness, ED (end diastolic) 1.4 cm (H)", "IVS (Interventricular septum) thickness, ED (end diastolic): 1.6 cm (H)/ IVS (Interventricular septum) thickness, ED (end diastolic): 1.2 cm", "BUN: 39 (H)/ BUN: 26 (H) mg/dl/ BUN: 35 (H)/ 24 (H)/ 33 (H)", "Calcium: 10.3 (H)/ Calcium: 10.2 (H)/ Calcium: 10.6 (H)", "Platelet: 144 (L)", "Potassium: 4.7 (H)", "CO2: 18 (L)", "Cholesterol: 251 (H)", "A1c: 6.2 %/ HgbA1C: 6.2 (H)", "Troponin I: 0.02 ng/ml", "Potassium: 3.6 meq/l", "ALT: 36 u/l", "Triglycerides: 369 (H) mg/dl", "LDL: 139 (H)", "VLDL: 74 (H)", "Diaphoresis", "WBC: 12.6 (H)/ WBC: 15.8 (H)", "RBC: 3.80 (L)/ RBC: 3.68 (L)/ 3.96 (L)/ 3.78 (L)", "Hemoglobin: 11.6 (L)/ Hemoglobin: 11.7 (L)/ 12.1 (L)", "Hematocrit: 33.8 (L)/ Hematocrit: 33.1 (L)/ 34.2 (L)", "Lymphocyte: 17.0 (L)/ Lymphocyte: 18.0 (L)/ 19.7 (L)/ 5.1 (L)", "CK: 290 (H)", "Neutrophil: 89.7 (H)", "INR: 1.20 (H)", "PT: 13.7 (H)", "Troponin I: 0.034 (H)/ 0.030 (H)", "Damage they did to my psyche, to my brain"; BNT162b2 (2nd dose; Pfizer BioNTech, 0.3 mL, Lot: EP7533, Expiry: 31Jul2021), administration date: 01Apr2020, when the patient was 76-year-old, for COVID-19 immunization, reaction(s): "had elevated creatlnine 1.8 with a GFR of 37/ eGFR: 45 (L)/ eGFR Non: 37 (L)/ eGFR: 51 (L)/ eGFR Non: 43 (L)/ eGFR Non: 59 (L)/ eGFR: 50 (L)/ eGFR Non: 42 (L)/ 55 (L)"; BNT162b2 (2nd dose; Pfizer BioNTech, 0.3 mL, Lot: EP7533, Expiry: 31Jul2021), administration date: 01Apr2021, for COVID-19 immunization, reaction(s): "Glucose Level: 125 (H)/ Glucose Level: 103 (H)/ Glucose Level: 108 (H)/ 138 (H)"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE, LOT:33030BD), administration date: 11Dec2021, when the patient was 77-year-old, for COVID-19 immunization, reaction(s): "PRESYNCOPE", "ALANINE AMINOTRANSFERASE INCREASED", "ASPARTATE AMINOTRANSFERASE INCREASED", "BLOOD CREATININE INCREASED", "PROTHROMBIN TIME PROLONGED", "BLOOD UREA INCREASED", "BLOOD GLUCOSE INCREASED", "BLOOD CALCIUM INCREASED", "PULMONARY GRANULOMA", "ORTHOPNOEA", "ATRIOVENTRICULAR BLOCK FIRST DEGREE", "DIZZINESS", "ASTHENIA", "ATRIAL FIBRILLATION", "HYPERTENSIVE CRISIS", "HYPERTENSION", "CARDIAC DISORDER", "RESPIRATORY ARREST", "DYSPNOEA", "HEART RATE DECREASED", "NODAL ARRHYTHMIA", "BRAIN INJURY", "MENTAL DISORDER", "CARDIAC DYSFUNCTION", "SINUS NODE DYSFUNCTION", "RESPIRATORY DISTRESS", "DEVICE MALFUNCTION", "ARRHYTHMIA", "FEELING ABNORMAL", "ACUTE KIDNEY INJURY", "CHEST PAIN", "HYPOACUSIS". The following information was reported: ORTHOPNOEA (non-serious) with onset Jun2024, outcome "recovering", described as "Positive for orthopnea"; DYSPNOEA (hospitalization), outcome "unknown", described as "shortness of breath"; CONDITION AGGRAVATED (hospitalization), outcome "not recovered", described as "symptoms are progressively getting worse"; COUGH (non-serious), outcome "unknown"; PAINFUL RESPIRATION (non-serious), outcome "unknown", described as "pain on the sides when he takes a deep breathe.". The patient was hospitalized for dyspnoea (hospitalization duration: 7 day(s)). The events "shortness of breath", "symptoms are progressively getting worse", "cough" and "positive for orthopnea" required emergency room visit. The patient underwent the following laboratory tests and procedures: Activated partial thromboplastin time: (29Apr2022) 32.5 seconds; (15May2022) 33.1 seconds; Activated partial thromboplastin time prolonged (22-32): (07May2021) 35.6 seconds; (16Oct2021) 34 (High); (04Feb2023) 36 (High); Alanine aminotransferase (5-54): (15May2022) 28 IU/l; Alanine aminotransferase normal (16-61): (11May2021) 19 IU/l; (12May2021) 15 IU/l; (13May2021) 15 IU/l; (15May2021) 15 IU/l; (17Aug2021) 36 IU/l; (16Oct2021) 52 (Normal); (03Feb2023) 33 (Normal); (04Feb2023) 33 (Normal); (27Mar2023) 43 IU/l; (27May2023) 55 (Normal); (19Jan2024) 59 (Normal); (21Jan2024) 44 (Normal); (12Feb2024) 42 (Normal); Albumin globulin ratio (0.8-2.0): (11May2021) 1.2; (12May2021) 1.3; (13May2021) 1.1; (15May2021) 0.9; (17Aug2021) 1.2; (16Oct2021) 1.1 (Normal); (15May2022) 1.4; (03Feb2023) 1.2 (Normal); (04Feb2023) 1.2 (Normal); (27Mar2023) 1.2; (27May2023) 1.1 (Normal); (19Jan2024) 1.0 (Normal); (21Jan2024) 1.0 (Normal); (12Feb2024) 1.1 (Normal); Albumin urine: (12Feb2024) 0.7 (N/A); Anion gap: (15May2022) 11; Anion gap (5-17): (07May2021) 9 mmol/L; (11May2021) 8 mmol/L; (12May2021) 7 mmol/L; (13May2021) 8 mmol/L; (15May2021) 10 mmol/L; (17Aug2021) 10 mmol/L; (18Aug2021) 12 mmol/L; (19Aug2021) 10 mmol/L; (16Oct2021) 8 mmol/L; (17Oct2021) 5 (Normal); (03Feb2023) 3 Low; (04Feb2023) 6 (Normal); (05Feb2023) 5 (Normal); (27Mar2023) 8 mmol/L; (27May2023) 3 Low; (28May2023) 7 (Normal); (29May2023) 7 (Normal); (30May2023) 4 (Low); (31May2023) 7 (Normal); (04Oct2023) 4 Low; (19Jan2024) 5 (Normal); (21Jan2024) 5 (Normal); (12Feb2024) 6 (Normal); (13Feb2024) <3 (Low); (14Feb2024) <3 (Low); (17Feb2024) <3 (Low); (18Feb2024) <3 (Low); Aspartate aminotransferase (9-34): (15May2022) 27 IU/l; Aspartate aminotransferase (15-37): (11May2021) 18 IU/l; (12May2021) 20 IU/l; (13May2021) 20 IU/l; (15May2021) 19 IU/l; (17Aug2021) 27 IU/l; (16Oct2021) 32 (Normal); (03Feb2023) 31 (Normal); (04Feb2023) 31 (Normal); (27Mar2023) 34 IU/l; (27May2023) 17 (Normal); (19Jan2024) 34 (Normal); (21Jan2024) 22 (Normal); (12Feb2024) 25 (Normal); Atrial pressure: (16Oct2021) 62; (04Oct2023) 72; Bacterial test: (27May2023) None Seen /HPF (Normal); Basophil count (0.00-0.10): (16Oct2021) 0.05 x10e3/mcL; (17Oct2021) 0.06 x10e3/mcL (Normal); (03Feb2023) 0.04 x10e3/mcL; (04Feb2023) 0.04 x10e3/mcL (Normal); (05Feb2023) 0.06 x10e3/mcL (Normal); (27Mar2023) 0.06 x10e3/mcL; (27May2023) 0.02 x10e3/mcL (Normal); (04Oct2023) 0.04 x 10e3/mcL; (19Jan2024) 0.04 x 10e3/mcL; (21Jan2024) 0.05 x 10e3/mcL (Normal); (11Feb2024) 0.06 x10e3/mcL (Normal); (13Feb2024) 0.03 x10e3/mcL; (14Feb2024) 0.04 x10e3/mcL (Normal); (15Feb2024) 0.03 x10e3/mcL; (16Feb2024) 0.05 x10e3/mcL; (17Feb2024) 0.05 x10e3/mcL (Normal); (18Feb2024) 0.04 x10e3/mcL (Normal); Basophil percentage: (07May2021) 1.1 %; (11May2021) 0.1 %; (12May2021) 0.4 %; (13May2021) 0.6 %; (15May2021) 0.5 %; (17Aug2021) 0.5 %; (18Aug2021) 1.0 %; (19Aug2021) 0.6 %; (16Oct2021) 0.6 (N/A); (17Oct2021) 0.7 (N/A); (29Apr2022) 0.9 %; (15May2022) 0.8 %; (03Feb2023) 0.5 NA; (04Feb2023) 0.5 (N/A); (05Feb2023) 0.8 (N/A); (27Mar2023) 0.6 %; (27May2023) 0.2 (N/A); (04Oct2023) 0.6 (N/A); (19Jan2024) 0.3 %; (21Jan2024) 0.4 (N/A); (11Feb2024) 0.6 (N/A); (13Feb2024) 0.4 %; (14Feb2024) 0.4 (N/A); (15Feb2024) 0.6 %; (16Feb2024) 0.4 %; (17Feb2024) 0.7 (N/A); (18Feb2024) 0.5 (N/A); Blood albumin (3.4-5.0): (29Apr2022) 4.0 g/dl; (15May2022) 4.1 g/dl; Blood albumin: (11May2021) 3.8 g/dl; (12May2021) 3.8 g/dl; (13May2021) 3.6 g/dl; (15May2021) 3.3 g/dl; (17Aug2021) 4.2 g/dl; (19Aug2021) 3.9 g/dl; (16Oct2021) 4.2 (Normal); (03Feb2023) 3.7 g/dl; (04Feb2023) 4.2 (Normal); (05Feb2023) 4.0 (Normal); (27Mar2023) 4.2 g/dl; (27May2023) 3.6 g/dl; (28May2023) 3.3 (Normal); (29May2023) 3.4 (Normal); (30May2023) 3.6 (Normal); (31May2023) 3.4 (Normal); (19Jan2024) 3.6 (Normal); (21Jan2024) 3.4 (Normal); (12Feb2024) 3.6 (Normal); (13Feb2024) 3.1 L; (14Feb2024) 3.4 (Normal); (15Feb2024) 3.1 L; (16Feb2024) 3.1 L; (17Feb2024) 3.3 (Low); (18Feb2024) 3.1 (Low); Blood alkaline phosphatase (46-116): (11May2021) 42 IU/l; (12May2021) 42 IU/l; (13May2021) 44 IU/l; (15May2021) 44 IU/l; (17Aug2021) 69 IU/l; (16Oct2021) 64 (Normal); (03Feb2023) 61 (Normal); (04Feb2023) 61 (Normal); (27Mar2023) 73 IU/l; (27May2023) 42 (Low); (19Jan2024) 64 (Normal); (21Jan2024) 54 (Normal); (12Feb2024) 55 (Normal); Blood alkaline phosphatase (25-120): (29Apr2022) 53 IU/l; (15May2022) 58 IU/l; Blood bilirubin (0.2-1.0): (29Apr2022) 0.8 mg/dl; (15May2022) 0.5 mg/dl; (11May2021) 0.6 mg/dl; (12May2021) 0.8 mg/dl; (13May2021) 0.9 mg/dl; (15May2021) 1.1 mg/dl; (17Aug2021) 0.3 mg/dl; (16Oct2021) 0.6 (Normal); (03Feb2023) 0.6 (Normal); (04Feb2023) 0.6 (Normal); (27Mar2023) 0.5 mg/dl; (27May2023) 0.7 (Normal); (19Jan2024) 0.5 (Normal); (21Jan2024) 0.9 (Normal); (12Feb2024) 1.1 (High); Blood calcium (8.5-10.1): (07May2021) 10.6 H; (11May2021) 9.6 mg/dl; (12May2021) 9.9 mg/dl; (13May2021) 10.0 mg/dl; (15May2021) 9.9 mg/dl; (17Aug2021) 10.3 mg/dl; (18Aug2021) 10.2 mg/dl; (19Aug2021) 9.7 mg/dl; (16Oct2021) 9.8 mg/dl; (17Oct2021) 9.4 (Normal); (15May2022) 10.3 (H); (03Feb2023) 9.2 mg/dl; (04Feb2023) 9.8 (Normal); (05Feb2023) 10.0 (Normal); (27Mar2023) 10.0 mg/dl; (27May2023) 9.3 mg/dl; (28May2023) 9.5 (Normal); (29May2023) 9.4 (Normal); (30May2023) 9.5 (Normal); (31May2023) 9.4 (Normal); (04Oct2023) 9.2 mg/dl; (19Jan2024) 9.5 (Normal); (21Jan2024) 9.8 (Normal); (11Feb2024) 9.9 mg/dl; (12Feb2024) 9.7 (Normal); (13Feb2024) 9.7 mg/dl; (14Feb2024) 10.2 (High); (15Feb2024) 9.5 mg/dl; (16Feb2024) 9.4 mg/dl; (17Feb2024) 9.5 (Normal); (18Feb2024) 9.6 (Normal); Blood chloride (98-107): (07May2021) 108 mmol/L; (11May2021) 106 mmol/L; (12May2021) 105 mmol/L; (13May2021) 102 mmol/L; (15May2021) 102 mmol/L; (17Aug2021) 108 mmol/L; (18Aug2021) 110 mmol/L; (19Aug2021) 109 mmol/L; (16Oct2021) 106 mmol/L; (17Oct2021) 107 (Normal); (03Feb2023) 110 HI; (04Feb2023) 105 (Normal); (05Feb2023) 105 (Normal); (27Mar2023) 105 mmol/L; (27May2023) 111 HI; (28May2023) 110 (High); (29May2023) 104 (Normal); (30May2023) 108 (High); (31May2023) 105 mmol/L (Normal); (04Oct2023) 110 HI; (19Jan2024) 103 (Normal); (21Jan2024) 103 (Normal); (11Feb2024) 108 H; (12Feb2024) 111 (High); (13Feb2024) 115 H; (14Feb2024) 112 (High); (15Feb2024) 111 H; (16Feb2024) 116 H; (17Feb2024) 112 (High); (18Feb2024) 112 (High); Blood chloride (98-111): (29Apr2022) 107 mmol/L; (15May2022) 109 mmol/L; Blood cholesterol: (18Aug2021) 6.61; (17Oct2021) 4 (Normal); (04Feb2023) 3 (Normal); (27May2023) 4 (Normal); Blood cholesterol (140-200): (18Aug2021) 251 H; (17Oct2021) 193 (Normal); (04Feb2023) 199 (Normal); (27May2023) 216 (High); Blood creatine: (29Apr2022) 1.24 mg/dl; (15May2022) 1.17 mg/dl; Blood creatine phosphokinase (30-234): (07May2021) 290 H; (11May2021) 204 IU/l; (12May2021) 210 IU/l; (13May2021) 174 IU/l; (15May2021) 101 IU/l; (17Aug2021) 185 IU/l; (12Feb2024) 123 (Normal); Blood creatine phosphokinase MB: (11May2021) 5.4; Blood creatinine (0.700-1.300): (unspecified date) 2.2 mg/dl; (07May2021) 1.27 mg/dl; (11May2021) 1.16 mg/dl; (12May2021) 1.05 mg/dl; (13May2021) 1.16 mg/dl; (15May2021) 1.62 mg/dl; (17Aug2021) 1.80 H; (18Aug2021) 1.59 H; (19Aug2021) 1.20 mg/dl; (03Feb2023) 1.230 mg/dl; (04Feb2023) 1.430 (High); (05Feb2023) 1.450 (High); (27Mar2023) 1.520 mg/dl; (27May2023) 1.410 HI; (28May2023) 1.520 (High); (29May2023) 1.730 (High); (30May2023) 1.440 (High); (31May2023) 1.410 (High); (04Oct2023) 2.440 HI; (19Jan2024) 2.240 (High); (21Jan2024) 2.390 (High); (11Feb2024) 4.020 H; (12Feb2024) 3.190 (High); (13Feb2024) 2.220 H; (14Feb2024) 1.820 (High); (15Feb2024) 1.920 H; (16Feb2024) 1.590 H; (17Feb2024) 1.610 (High); (18Feb2024) 1.510 (High); Blood creatinine: (unspecified date) Elevated; (16Oct2021) 1.280; (17Oct2021) 1.140 (Normal); Blood glucose: (18Aug2021) 131 mg/dl; Blood glucose (74-106): (07May2021) 95 mg/dl; (11May2021) 138 H; (12May2021) 103 H; (13May2021) 108 H; (15May2021) 95 mg/dl; (17Aug2021) 125 H; (18Aug2021) 88 mg/dl; (19Aug2021) 93 mg/dl; (16Oct2021) 94 mg/dl; (17Oct2021) 96 (Normal); (03Feb2023) 119 HI; (04Feb2023) 105 (Normal); (05Feb2023) 109 (High); (27Mar2023) 131 mg/dl; (27May2023) 103 mg/dl; (28May2023) 180 (High); (29May2023) 214 (High); (30May2023) 148 (High); (31May2023) 118 (High); (04Oct2023) 139 HI; (19Jan2024) 130 (High); (21Jan2024) 142 (High); (11Feb2024) 112 H; (12Feb2024) 115 (High); (13Feb2024) 101 mg/dl; (14Feb2024) 100 (Normal); (15Feb2024) 103 mg/dl; (16Feb2024) 114 H; (17Feb2024) 112 (High); (18Feb2024) 117 (High); Blood glucose (65-99): (29Apr2022) 100 mg/dl; (15May2022) 96 mg/dl; Blood magnesium (1.8-2.4): (11May2021) 1.7 mg/dl; (12May2021) 2.1 mg/dl; (13May2021) 1.9 mg/dl; (17Aug2021) 2.0 mg/dl; (18Aug2021) 2.1 mg/dl; (19Aug2021) 1.8 mg/dl; (17Oct2021) 2.4 (Normal); (04Feb2023) 2.4 (Normal); (05Feb2023) 2.4 (Normal); (28May2023) 2.5 (High); (29May2023) 2.4 (Normal); (30May2023) 2.4 (Normal); (31May2023) 2.4 (Normal); (21Jan2024) 2.6 (High); (12Feb2024) 2.2 (Normal); (13Feb2024) 2.4 mg/dl; (14Feb2024) 2.4 (Normal); (15Feb2024) 2.2 mg/dl; (16Feb2024) 2.2 mg/dl; (17Feb2024) 2.3 (Normal); (18Feb2024) 2.3 (Normal); Blood osmolarity (275-295): (16Oct2021) 280 mOsmol/kg; (17Oct2021) 272 mOsmol/kg (Low); (03Feb2023) 286 mOsmol/kg (Normal); (27Mar2023) 287 mOsmol/kg; (27May2023) 285, notes: 285 mOsmol/kg (Normal); (04Oct2023) 297 HI, notes: 297 mOsmol/kg; (19Jan2024) 309 (High), notes: 309 mOsmol/kg (High); (21Jan2024) 304 (High), notes: 304 mOsmol/kg (High); (12Feb2024) 310 (High), notes: 310 mOsmol/kg (High); Blood pH: (14Feb2024) 7.38 (Normal); Blood phosphorus: (19Aug2021) 3.3 mg/dl; (04Feb2023) 3.4 (Normal); (05Feb2023) 3.1 (Normal); (28May2023) 3.5 (Normal); (29May2023) 4.4 (Normal); (30May2023) 3.2 (Normal); (31May2023) 4.1 (Normal); (13Feb2024) 3.2 mg/dl; (14Feb2024) 2.5 (Low); (15Feb2024) 3.2 mg/dl; (16Feb2024) 3.6 mg/dl; (17Feb2024) 3.3 (Normal); (18Feb2024) 2.7 (Normal); Blood potassium (3.5-5.1): (07May2021) 3.9 mmol/L; (11May2021) 4.5 mmol/L; (12May2021) 4.1 mmol/L; (13May2021) 4.1 mmol/L; (15May2021) 3.8 mmol/L; (17Aug2021) 3.9 mmol/L; (18Aug2021) 4.7 H; (19Aug2021) 3.6 mmol/L; (16Oct2021) 3.9 mmol/L; (17Oct2021) 3.9 (Normal); (03Feb2023) 3.9 mmol/L; (04Feb2023) 3.5 (Normal); (05Feb2023) 4.1 (Normal); (27Mar2023) 4.0 mmol/L; (27May2023) 4.3 mmol/L; (28May2023) 4.2 (Normal); (29May2023) 3.9 (Normal); (30May2023) 3.6 (Normal); (31May2023) 3.7 (Normal); (04Oct2023) 4.0 mmol/L; (19Jan2024) 3.9 (Normal); (21Jan2024) 3.6 (Normal); (11Feb2024) 4.2 mmol/L; (12Feb2024) 3.7 (Normal); (13Feb2024) 3.6 mmol/L; (14Feb2024) 3.7 (Normal); (15Feb2024) 3.7 mmol/L; (16Feb2024) 3.5 mmol/L; (17Feb2024) 3.8 (Normal); (18Feb2024) 3.5 (Normal); Blood potassium: (29Apr2022) 4.4 mmol/L; (15May2022) 4.0 mmol/L; Blood pressure diastolic (63-90): (28Mar2023) 83; (31May2023) 88; (20Jan2024) 63; Blood pressure diastolic: (16Oct2021) 104 >HHI; (03Feb2023) C 102; (04Feb2023) 65 mmHg; (05Feb2023) 64 mmHg; (27Mar2023) 77 mmHg; (30Apr2023) 80 mmHg; (28May2023) 93 mmHg; (04Oct2023) 93 mmHg; (04Oct2023) 82 mmHg; (21Jan2024) 66 mmHg; (11Feb2024) 63 mmHg; (12Feb2024) 87 mmHg; (13Feb2024) 75 mmHg; (16Feb2024) 62 mmHg; (17Feb2024) 105 mmHg; (18Feb2024) 85 mmHg; Blood pressure measurement: (unspecified date) 120/90; (16Oct2021) 166/89; (18Feb2024) 141/85; Blood pressure systolic: (16Oct2021) 172 HI; (03Feb2023) 117 mmHg; (04Feb2023) 125 mmHg; (05Feb2023) 124 mmHg; (27Mar2023) 189 mmHg; (28Mar2023) 140 mmHg; (30Apr2023) 148 mmHg; (28May2023) 173 mmHg; (31May2023) 141 mmHg; (04Oct2023) 146 mmHg; (04Oct2023) 144 mmHg; (21Jan2024) 121 mmHg; (11Feb2024) 110 mmHg; (12Feb2024) 132 mmHg; (13Feb2024) H 148; (16Feb2024) 126 mmHg; (17Feb2024) 124 mmHg; (18Feb2024) 141 mmHg; Blood sodium (134-144): (29Apr2022) 140 mmol/L; (15May2022) 141 mmol/L; Blood sodium (136-145): (07May2021) 142 mmol/L; (11May2021) 139 mmol/L; (12May2021) 139 mmol/L; (13May2021) 139 mmol/L; (15May2021) 137 mmol/L; (17Aug2021) 144 mmol/L; (18Aug2021) 140 mmol/L; (19Aug2021) 142 mmol/L; (16Oct2021) 138 mmol/L; (17Oct2021) 134 (Low); (03Feb2023) 141 mmol/L; (04Feb2023) 139 (Normal); (05Feb2023) 137 (Normal); (27Mar2023) 138 mmol/L; (27May2023) 138 mmol/L; (28May2023) 138 (Normal); (29May2023) 135 (Low); (30May2023) 138 (Normal); (31May2023) 136 (Normal); (04Oct2023) 140 mmol/L; (19Jan2024) 140 (Normal); (21Jan2024) 140 (Normal); (11Feb2024) 140 mmol/L; (12Feb2024) 141 (Normal); (13Feb2024) 144 mmol/L; (14Feb2024) 142 (Normal); (15Feb2024) 141 mmol/L; (16Feb2024) 145 mmol/L; (17Feb2024) 143 (Normal); (18Feb2024) 141 (Normal); Blood thyroid stimulating hormone: (17Aug2021) 2.78 MiU/mL; (04Feb2023) 7.590 (High); (27May2023) 0.960 (Normal); Blood triglycerides (30-150): (18Aug2021) 369 H; (17Oct2021) 173 (High); (04Feb2023) 196 (High); (27May2023) 141  (Normal); Blood urea (7-18): (unspecified date) 19 mg/dl; (07May2021) 33 H; (11May2021) 24 H; (12May2021) 23 mg/dl; (13May2021) 19 mg/dl; (15May2021) 35 H; (17Aug2021) 39 H; (18Aug2021) 39 H; (19Aug2021) 26 H; (16Oct2021) 25 HI; (17Oct2021) 24 (High); (03Feb2023) 24 HI; (04Feb2023) 22 (High); (05Feb2023) 28 (High); (27Mar2023) 40 mg/dl; (27May2023) 37 HI; (28May2023) 38 (High); (29May2023) 54 (High); (30May2023) 49 (High); (31May2023) 47 (High); (04Oct2023) 55 HI; (19Jan2024) 90 (High); (21Jan2024) 76 (High); (11Feb2024) 104 H; (12Feb2024) 90 (High); (13Feb2024) 72 H; (14Feb2024) 50 (High); (15Feb2024) 47 H; (16Feb2024) 42 H; (17Feb2024) 34 (High); (18Feb2024) 35 (High); Blood urea (5-23): (29Apr2022) 24 mg/dl; (15May2022) 25 (H); Blood urea nitrogen/creatinine ratio: (29Apr2022) 19.4; (15May2022) 21.4; Blood urea nitrogen/creatinine ratio (6-22): (07May2021) 26.0; (11May2021) 20.7; (12May2021) 21.9; (13May2021) 16.4; (15May2021) 21.6; (17Aug2021) 21.7; (18Aug2021) 24.5; (19Aug2021) 21.7; (16Oct2021) 20; (17Oct2021) 21 (Normal); (03Feb2023) 20; (04Feb2023) 15 (Normal); (05Feb2023) 19 (Normal); (27Mar2023) 26; (27May2023) 26 HI; (28May2023) 25 (High); (29May2023) 31 (High); (30May2023) 34 (High); (31May2023) 33 (High); (04Oct2023) 22; (19Jan2024) 40 HI; (21Jan2024) 32 (High); (11Feb2024) 26 H; (12Feb2024) 28 (High); (13Feb2024) 32 H; (14Feb2024) 28 (High); (15Feb2024) 24 H; (16Feb2024) 26 H; (17Feb2024) 21 (Normal); (18Feb2024) 23 (High); Blood uric acid: (12Feb2024) 13.1 (High); Blood urine present: (07May2021) Negative; (16Oct2021) Negative (Normal); (04Feb2023) Negative (Normal); (27May2023) Negative (Normal); Body height: (16Oct2021) 168 cm; (02Feb2023) 167.64; (27Mar2023) 167.64; (30Apr2023) 167.64 cm; (11Feb2024) 167.64 cm; Body mass index: (16Oct2021) 32.14 kg/m2; (02Feb2023) 29.86; (27Mar2023) 30.35 kg/m2; (30Apr2023) 29.86 kg/m2; (04Oct2023) 30.02; (19Jan2024) 30.02 kg/m2; (11Feb2024) 29.37 kg/m2; Body surface area: (02Feb2023) 1.98; (27Mar2023) 1.99; (30Apr2023) 1.98 m2; (04Oct2023) 1.98; (19Jan2024) 1.98 m2; Body temperature (36.5-36.5): (16Oct2021) 37 Centigrade; (03Feb2023) 36.6 Centigrade; (04Feb2023) L 36.3; (05Feb2023) 36.7 Centigrade; (27Mar2023) 36.7 Centigrade; (30Apr2023) 37 Centigrade; (28May2023) 36.6 Centigrade; (31May2023) 36.8 Centigrade; (20Jan2024) 36.6 Centigrade; (21Jan2024) 36.3 Centigrade; (11Feb2024) 36.8 Centigrade; (12Feb2024) 37.6 Centigrade; (16Feb2024) 36.7 Centigrade; (17Feb2024) 36.5 Centigrade; (18Feb2024) 36.5 Centigrade; Body temperature: (unspecified date) 97.7 Fahrenheit; (30Apr2023) 98.6 Fahrenheit; Carbon dioxide (21-32): (07May2021) 25 mmol/L; (11May2021) 25 mmol/L; (12May2021) 27 mmol/L; (13May2021) 29 mmol/L; (15May2021) 25 mmol/L; (17Aug2021) 26 mmol/L; (18Aug2021) 18 L; (19Aug2021) 23 mmol/L; (16Oct2021) 24 mmol/L; (17Oct2021) 22 (Normal); (03Feb2023) 28 mmol/L; (04Feb2023) 28 (Normal); (05Feb2023) 27 (Normal); (27Mar2023) 25 mmol/L; (27May2023) 24 mmol/L; (28May2023) 21 (Normal); (29May2023) 24 (Normal); (30May2023) 26 (Normal); (31May2023) 24 (Normal); (04Oct2023) 26 mmol/L; (19Jan2024) 32 (Normal); (21Jan2024) 33 (High); (11Feb2024) 25 mmol/L; (12Feb2024) 24 (Normal); (13Feb2024) 27 mmol/L; (14Feb2024) 28 (Normal); (15Feb2024) 29 mmol/L; (16Feb2024) 28 mmol/L; (17Feb2024) 31 (Normal); (18Feb2024) 29 (Normal); Carbon dioxide (19-29): (29Apr2022) 23 mmol/L; (15May2022) 21 mmol/L; Chest X-ray: (16Oct2021) Unknown results, notes: XR Chest 1 View Frontal; (27Mar2023) Unknown results, notes: XR Chest 1 View Frontal; Computerised tomogram: (unspecified date) No evidence PE, notes: 1. No evidence PE. 2. Findings consistent with the sequela of prior benign granulomatous disease. 3. Mild nonspecific ground glass opacities within the left upper lobe; Creatine urine: (20Jan2024) 101.4 (N/A); (12Feb2024) 44.7 (N/A); Creatinine renal clearance: (16Oct2021) 43.84 ml/min; (17Oct2021) 49.22 ml/min; (03Feb2023) 44.67 ml/min; (04Feb2023) 38.42 ml/min; (05Feb2023) 37.89 ml/min; (27Mar2023) 36.14 ml/min; (27May2023) 38.96 ml/min; (28May2023) 36.14 ml/min; (29May2023) 31.76 ml/min; (30May2023) 38.15 ml/min; (31May2023) 38.96 ml/min; (19Jan2024) 24.13 ml/min; (21Jan2024) 23.10 ml/min; (12Feb2024) 16.94 ml/min; (14Feb2024) 29.70 ml/min; (17Feb2024) 33.57 ml/min; (18Feb2024) 35.80 ml/min; Crystal urine present: (07May2021) Negative; (16Oct2021) Negative (Normal); (04Feb2023) Negative (Normal); (27May2023) Negative (Normal); Culture urine: (07May2021) Not indicated; (27May2023) No (Normal); Electrocardiogram PR interval: (16Oct2021) 120; (04Oct2023) 200; Electrocardiogram QRS complex: (16Oct2021) 92; (27Mar2023) 96; (04Oct2023) 88; Electrocardiogram QT interval: (16Oct2021) 410; (27Mar2023) 398; (04Oct2023) 384; (16Oct2021) 416; (27Mar2023) 429; (04Oct2023) 420; Eosinophil count (0.00-0.40): (16Oct2021) 0.28 x10e3/mcL; (17Oct2021) 0.28 x10e3/mcL (Normal); (03Feb2023) 0.33 x10e3/mcL; (04Feb2023) 0.23 x10e3/mcL (Normal); (05Feb2023) 0.41 x10e3/mcL (High); (27Mar2023) 0.37 x10e3/mcL; (27May2023) 0.11 x10e3/mcL (Normal); (04Oct2023) 0.55 x 10e3/mcL HI; (19Jan2024) 0.29 x 10e3/mcL; (21Jan2024) 0.46 x 10e3/mcL (High); (11Feb2024) 0.21 x10e3/mcL (Normal); (13Feb2024) 0.18 x10e3/mcL; (14Feb2024) 0.21 x10e3/mcL (Normal); (15Feb2024) 0.22 x10e3/mcL; (16Feb2024) 0.27 x10e3/mcL; (17Feb2024) 0.29 x10e3/mcL (Normal); (18Feb2024) 0.24 x10e3/mcL (Normal); Eosinophil percentage: (07May2021) 5.3 %; (12May2021) 0.4 %; (13May2021) 1.0 %; (15May2021) 3.7 %; (17Aug2021) 5.4 %; (18Aug2021) 5.6 %; (19Aug2021) 4.2 %; (16Oct2021) 3.4 (N/A); (17Oct2021) 3.5 (N/A); (29Apr2022) 2.6 %; (15May2022) 2.7 %; (03Feb2023) 3.8 NA; (04Feb2023) 2.8 (N/A); (05Feb2023) 5.6 (N/A); (27Mar2023) 3.7 %; (27May2023) 1.0 (N/A); (04Oct2023) 7.6 (N/A); (19Jan2024) 2.3 %; (21Jan2024) 3.3 (NA); (11Feb2024) 2.1 (N/A); (13Feb2024) 2.2 %; (14Feb2024) 2.3 (N/A); (15Feb2024) 2.5 %; (16Feb2024) 4.0 %; (17Feb2024) 4.1 (N/A); (18Feb2024) 3.2 (N/A); Fibrin D dimer: (16Oct2021) 0.26 mcg/mL FEU (Normal); (03Feb2023) 0.29 mcg/mL FEU; (28Mar2023) 0.33 ug/ml; (14Feb2024) 1.82 mcg/mL FEU (High); Globulin: (11May2021) 3.1; (12May2021) 3.0; (13May2021) 3.4; (15May2021) 3.5; (17Aug2021) 3.4; (15May2022) 2.9; Glomerular filtration rate: (07May2021) >60/55L, notes: eGFR: >60 eGFR: 55 L; (11May2021) >60 ml/min, notes: eGFR: >60 eGFR: >60; (12May2021) >60 ml/min, notes: eGFR: >60 eGFR: >60; (13May2021) >60 ml/min, notes: eGFR: >60 eGFR: >60; (15May2021) 50 L/42 L, notes: eGFR: 50 L eGFR Non: 42 L; (17Aug2021) 37 ml/min, notes: eGFR Non: 37; (17Aug2021) 45 ml/min, notes: eGFR 45; (18Aug2021) 43 ml/min, notes: eGFR Non: 43; (18Aug2021) 51 L, notes: eGFR 51; (19Aug2021) 59 ml/min, notes: eGFR: 59; (19Aug2021) >60 L, notes: eGFR >60; (17Oct2021) 62 ml/min, notes: eGFR: 62 mL/min/1.73m2 (Normal); (17Oct2021) 72 ml/min, notes: eGFR: 72 mL/min/1.73m2 (Normal); (03Feb2023) 60 ml/min, notes: 60 mL/min/1.73m2 NA; (04Feb2023) 50 ml/min, notes: 50 mL/min/1.73m2 (N/A); (05Feb2023) 49 ml/min, notes: 49 mL/min/1.73m2 (N/A); (27Mar2023) 47 ml/min, notes: 47 mL/min/1.73m2; (27May2023) 51 ml/min, notes: 51 mL/min/1.73m2 NA; (28May2023) 47 ml/min, notes: 47 mL/min/1.73m2 (N/A); (29May2023) 40 ml/min, notes: 40 mL/min/1.73m2 (N/A); (30May2023) 50 ml/min, notes: 50 mL/min/1.73m2 (N/A); (31May2023) 51 ml/min, notes: 51 mL/min/1.73m2 (N/A); (04Oct2023) 26 ml/min, notes: 26 ml/min 1.73 m2 (N/A); (19Jan2024) 29 ml/min, notes: 29 ml/min 1.73 m2 (N/A); (21Jan2024) 27 ml/min, notes: 27 ml/min 1.73 m2 (N/A); (12Feb2024) 19 ml/min, notes: 19 ml/min/1.73 m2 (N/A); (14Feb2024) 37 ml/min, notes: 37 mL/min/1.73m2 (N/A); (17Feb2024) 43 ml/min, notes: 43 mL/min/1.73m2 (N/A); (18Feb2024) 47 ml/min, notes: 47 mL/min/1.73m2 (N/A); Glomerular filtration rate: (15May2022) greater than 60; (15May2022) 60, notes: greater than equal to 60; Glucose urine: (07May2021) Negative; (16Oct2021) Negative (Normal); (04Feb2023) Negative (Normal); (27May2023) 1+ (Abnormal); Granulocyte percentage (0.0-0.8): (16Oct2021) 0.2 %; (17Oct2021) 0.1 (Normal); (03Feb2023) 0.3 %; (04Feb2023) 0.4 (Normal); (05Feb2023) 0.1 (Normal); (27Mar2023) 0.3 %; (27May2023) 1.1 (High); (04Oct2023) 0.4 %; (19Jan2024) 0.6 %; (21Jan2024) 0.5 (Normal); (11Feb2024) 0.5 (Normal); (13Feb2024) 0.2 %; (14Feb2024) 0.3 (Normal); (15Feb2024) 0.5 %; (16Feb2024) 0.4 %; (17Feb2024) 0.3 (Normal); (18Feb2024) 0.3 (Normal); Haematocrit (37.0-52.0): (07May2021) 40.4 %; (11May2021) 34.2 L; (12May2021) 33.8 L; (13May2021) 35.4 %; (15May2021) 33.1 L; (17Aug2021) 40.4 %; (18Aug2021) 41.8 %; (19Aug2021) 38.9 %; (16Oct2021) 42.9 %; (17Oct2021) 45.3 (Normal); (03Feb2023) 38.7 %; (04Feb2023) 43.4 (Normal); (05Feb2023) 44.3 (Normal); (27Mar2023) 41.5 %; (27May2023) 40.3 %; (28May2023) 35.2 (Low); (29May2023) 37.0 (Normal); (30May2023) 40.4 (Normal); (31May2023) 43.5 (Normal); (04Oct2023) 35.2 Low; (19Jan2024) 38.3 %; (21Jan2024) 37.4 (Normal); (11Feb2024) 35.7 L; (12Feb2024) 34.0 (Low); (13Feb2024) 33.6 L; (14Feb2024) 36.9 % (Low); (15Feb2024) 34.5 L; (16Feb2024) 32.4 L; (17Feb2024) 37.5 (Normal); (18Feb2024) 33.2 (Low); (29Apr2022) 40.3 %; (15May2022) 40.6 %; Haemoglobin (12.3-17.2): (07May2021) 13.6 g/dl; (11May2021) 11.7 L; (12May2021) 11.6 L; (13May2021) 12.1 L; (15May2021) 11.7 L; (17Aug2021) 13.6 g/dl; (18Aug2021) 13.9 g/dl; (19Aug2021) 13.6 g/dl; (16Oct2021) 14.6 g/dl; (17Oct2021) 14.3 (Normal); (29Apr2022) 13.9 g/dl; (15May2022) 17.5 g/dl; (03Feb2023) 13.1 g/dl; (04Feb2023) 14.8 (Normal); (05Feb2023) 14.7 (Normal); (27Mar2023) 14.3 g/dl; (27May2023) 13.0 g/dl; (28May2023) 11.8 (Low); (29May2023) 12.4 (Normal); (30May2023) 13.3 (Normal); (31May2023) 13.8 (Normal); (04Oct2023) 11.4 Low; (19Jan2024) 12.3 g/dl; (21Jan2024) 12.1 (Low); (11Feb2024) 11.5 L; (12Feb2024) 10.7 (Low); (13Feb2024) 10.8 L; (14Feb2024) 11.5 (Low); (15Feb2024) 10.8 L; (16Feb2024) 10.4 L; (17Feb2024) 11.9 (Low); (18Feb2024) 10.6 (Low); Haemoglobin: (18Aug2021) 6.2 H, notes: Reference Range: <=5.5; (17Oct2021) 5.6 (Normal); (04Feb2023) 5.9 (High); (27May2023) 6.0 (High); Heart rate (68-99): (03Feb2023) 80; (28Mar2023) 69; (29May2023) 79; (31May2023) 71; (20Jan2024) 69; (11Feb2024) 69; (12Feb2024) 72; Heart rate: (16Oct2021) 64 bpm; (05Feb2023) 70; (27Mar2023) 67; (28Mar2023) 70; (30Apr2023) 83 bpm; (04Oct2023) 70; (04Oct2023) 75; (12Feb2024) 69; (13Feb2024) 70; (16Feb2024) 66; (17Feb2024) 71; (18Feb2024) 70; High density lipoprotein (35-65): (18Aug2021) 38 mg/dl; (17Oct2021) 44 (Normal); (04Feb2023) 60 (High); (27May2023) 62 (High); Immature granulocyte